These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 27984375)

  • 1. Survival After Pelvic Exenteration for Cervical Cancer: A National Cancer Database Study.
    Graves S; Seagle BL; Strohl AE; Shahabi S; Nieves-Neira W
    Int J Gynecol Cancer; 2017 Feb; 27(2):390-395. PubMed ID: 27984375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
    Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
    Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study.
    Seagle BL; Kanis M; Strohl AE; Shahabi S
    Gynecol Oncol; 2016 Dec; 143(3):636-641. PubMed ID: 27771166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival After Primary Debulking Surgery Compared With Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A National Cancer Database Study.
    Seagle BL; Graves S; Strohl AE; Shahabi S
    Int J Gynecol Cancer; 2017 Oct; 27(8):1610-1618. PubMed ID: 28763362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
    Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
    Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exenteration as a primary treatment for locally advanced cervical cancer: long-term results and prognostic factors.
    Forner DM; Lampe B
    Am J Obstet Gynecol; 2011 Aug; 205(2):148.e1-6. PubMed ID: 21640963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does histologic type correlate to outcome after pelvic exenteration for cervical and vaginal cancer?
    Baiocchi G; Guimaraes GC; Faloppa CC; Kumagai LY; Oliveira RA; Begnami MD; Soares FA; Lopes A
    Ann Surg Oncol; 2013 May; 20(5):1694-700. PubMed ID: 23212765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
    van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
    Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer.
    Schmidt AM; Imesch P; Fink D; Egger H
    Gynecol Oncol; 2012 Jun; 125(3):604-9. PubMed ID: 22406639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data-Derived Treatment Duration Goal for Cervical Cancer: Should 8 Weeks Remain the Target in the Era of Concurrent Chemoradiation?
    Hong JC; Foote J; Broadwater G; Sosa JA; Gaillard S; Havrilesky LJ; Chino JP
    JCO Clin Cancer Inform; 2017 Nov; 1():1-15. PubMed ID: 30657372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic exenteration for adenocarcinoma of the uterine cervix.
    Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
    Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of distance to closest negative margin on survival after pelvic exenteration.
    Martin AL; Sinha S; Peres LC; Hakam A; Chon HS; Hoffman MS; Shahzad MM; Wenham RM; Chern JY
    Gynecol Oncol; 2022 Jun; 165(3):514-521. PubMed ID: 35487774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of Care, Health Care Disparities, and Their Impact on Survival Outcomes in Stage IVB Cervical Cancer: A Nationwide Retrospective Cohort Study.
    Jalloul RJ; Sharma S; Tung CS; O'Donnell B; Ludwig M
    Int J Gynecol Cancer; 2018 Jun; 28(5):1003-1012. PubMed ID: 29757872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study.
    Seagle BL; Sobecki-Rausch J; Strohl AE; Shilpi A; Grace A; Shahabi S
    Gynecol Oncol; 2017 Apr; 145(1):61-70. PubMed ID: 28317559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
    Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
    Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
    Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
    Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy prior to pelvic exenteration in patients with recurrent cervical cancer: single institution experience.
    Landoni F; Zanagnolo V; Rosenberg PG; Lopes A; Radice D; Bocciolone L; Aletti G; Parma G; Colombo N; Maggioni A
    Gynecol Oncol; 2013 Jul; 130(1):69-74. PubMed ID: 23474343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix.
    Shingleton HM; Soong SJ; Gelder MS; Hatch KD; Baker VV; Austin JM
    Obstet Gynecol; 1989 Jun; 73(6):1027-34. PubMed ID: 2726106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcomes of clinical stage IIA/B seminoma: Results from the National Cancer Data Base 1998-2012.
    Paly JJ; Lin CC; Gray PJ; Hallemeier CL; Beard C; Sineshaw H; Jemal A; Efstathiou JA
    Pract Radiat Oncol; 2016; 6(6):e249-e258. PubMed ID: 27345128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.